Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 10, 2012 - Issue 11
Submit an article Journal homepage
156
Views
16
CrossRef citations to date
0
Altmetric
Review

Combined use of nonculture-based lab techniques in the diagnosis and management of critically ill patients with invasive fungal infections

Javier Pemán Servicio de Microbiología, Hospital Universitario y Politécnico La Fe, Valencia, Spain. [email protected]; Servicio de Microbiología, Hospital Universitario y Politécnico La Fe, Valencia, Spain. [email protected]
&
Rafael Zaragoza Servicio de Medicina Intensiva, Hospital Universitario Doctor Peset, Valencia, Spain; Servicio de Medicina Intensiva, Hospital Universitario Doctor Peset, Valencia, Spain
Pages 1321-1330 | Published online: 10 Jan 2014

References

  • Perfect JR, Cox GM, Lee JY et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin. Infect. Dis. 33(11), 1824–1833 (2001).
  • Pemán J, Zaragoza R. Hacia el diagnóstico temprano de la candidiasis invasora en el paciente crítico. Rev. Iberoam. Micol. 29(2), 71–75 (2012).
  • Ostrosky-Zeichner L. Invasive mycoses: diagnostic challenges. Am. J. Med. 125(Suppl. 1), S14–S24 (2012).
  • Pemán J, Zaragoza R. Current diagnostic approaches to invasive candidiasis in critical care settings. Mycoses 53(5), 424–433 (2010).
  • Leleu G, Aegerter P, Guidet B. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J. Crit. Care 17(3), 168–175 (2002).
  • Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and case–control studies. Eur. J. Clin. Microbiol. Infect. Dis. 25(7), 419–425 (2006).
  • Meersseman W, Lagrou K, Spriet I et al. Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med. 35(9), 1526–1531 (2009).
  • Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect. Dis. 5(10), 609–622 (2005).
  • Quindós G, Moragues MD, Pontón J. Is there a role for antibody testing in the diagnosis of invasive candidiasis? Rev. Iberoam. Micol. 21(1), 10–14 (2004).
  • Ostrosky-Zeichner L, Alexander BD, Kett DH et al. Multicenter clinical evaluation of the (1-->3) β-d-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis. 41(5), 654–659 (2005).
  • Moragues MD, Ortiz N, Iruretagoyena JR et al. Evaluación de un nuevo método comercial (Candida albicans IFA IgG) para el diagnóstico serológico de la candidiasis invasora. Enferm. Infecc. Microbiol. Clin. 22(2), 83–88 (2004).
  • Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C, Third European Conference on Infections in Leukemia Group. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit. Care 14(6), R222 (2010).
  • Khot PD, Fredricks DN. PCR-based diagnosis of human fungal infections. Expert Rev. Anti. Infect. Ther. 7(10), 1201–1221 (2009).
  • Pemán J, Zaragoza R, Quindós G et al. Clinical factors associated with a Candida albicans germ tube antibody positive test in intensive care unit patients. BMC Infect. Dis. 11(1), 60 (2011).
  • De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46(12), 1813–1821 (2008).
  • Acosta J, Catalan M, del Palacio-Pérez-Medel A et al. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-d-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease. Eur. J. Clin. Microbiol. Infect. Dis. 31(5), 721–731 (2012).
  • Mohr JF, Sims C, Paetznick V et al. Prospective survey of (1,3)-β-d-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J. Clin. Microbiol. 49(1), 58–61 (2011).
  • Posteraro B, De Pascale G, Tumbarello M et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1,3)-β-d-glucan assay, Candida score, and colonization index. Crit. Care 15(5), R249 (2011).
  • Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME. b-d-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin. Infect. Dis. 52(6), 750–770 (2011).
  • Onishi A, Sugiyama D, Kogata Y et al. Diagnostic accuracy of serum 1,3-β-d-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J. Clin. Microbiol. 50(1), 7–15 (2012).
  • Sims CR, Jaijakul S, Mohr J, Rodriguez J, Finkelman M, Ostrosky-Zeichner L. Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis. J. Clin. Microbiol. 50(6), 2104–2106 (2012).
  • Marchetti O, Lamoth F, Mikulska M, Viscoli C, Verweij P, Bretagne S. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant. 47(6), 846–854 (2012).
  • Verduyn Lunel FM, Donnelly JP, van der Lee HA, Blijlevens NM, Verweij PE. Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy. Clin. Microbiol. Infect. 15(4), 380–386 (2009).
  • Maertens J, Buvé K, Theunissen K et al. Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer 115(2), 355–362 (2009).
  • Zaragoza R, Pemán J, Quindós G et al. Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients. Clin. Microbiol. Infect. 15(6), 592–595 (2009).
  • Zaragoza R, Pemán J, Quindós G et al. Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality. Clin. Vaccine Immunol. 16(10), 1527–1528 (2009).
  • Laín A, Elguezabal N, Brena S et al. Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1. BMC Microbiol. 7, 35 (2007).
  • Laín A, Moragues MD, Ruiz JC et al. Evaluation of a novel enzyme-linked immunosorbent assay to detect immunoglobulin G antibody to enolase for serodiagnosis of invasive candidiasis. Clin. Vaccine Immunol. 14(3), 318–319 (2007).
  • Clancy CJ, Nguyen ML, Cheng S et al. Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis. J. Clin. Microbiol. 46(5), 1647–1654 (2008).
  • Nguyen MH, Clancy CJ. Biomarkers for diagnosis of candidal infections. Curr. Fungal Infect. Rep. 6, 56–62 (2012).
  • Maertens J, Deeren D, Dierickx D, Theunissen K. Preemptive antifungal therapy: still a way to go. Curr. Opin. Infect. Dis. 19(6), 551–556 (2006).
  • Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J. Clin. Microbiol. 49(2), 665–670 (2011).
  • Lau A, Halliday C, Chen SC, Playford EG, Stanley K, Sorrell TC. Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. J. Clin. Microbiol. 48(3), 811–816 (2010).
  • Mancini N, Clerici D, Diotti R et al. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J. Med. Microbiol. 57(Pt 5), 601–604 (2008).
  • Lucignano B, Ranno S, Liesenfeld O et al. Multiplex PCR allows rapid and accurate diagnosis of bloodstream infections in newborns and children with suspected sepsis. J. Clin. Microbiol. 49(6), 2252–2258 (2011).
  • Kühn C, Disqué C, Mühl H, Orszag P, Stiesch M, Haverich A. Evaluation of commercial universal rRNA gene PCR plus sequencing tests for identification of bacteria and fungi associated with infectious endocarditis. J. Clin. Microbiol. 49(8), 2919–2923 (2011).
  • Ruhnke M, Böhme A, Buchheidt D et al. Diagnosis of invasive fungal infections in hematology and oncology – guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO). Ann. Oncol. 23(4), 823–833 (2012).
  • Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin. Infect. Dis. 42(10), 1417–1427 (2006).
  • Martín-Rabadán P, Gijón P, Alonso Fernández R et al. False-positive Aspergillus antigenemia due to blood product conditioning fluids. Clin. Infect. Dis. 55(4), e22–e27 (2012).
  • Sulahian A, Touratier S, Ribaud P. False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N. Engl. J. Med. 349(24), 2366–2367 (2003).
  • Mennink-Kersten MA, Klont RR, Warris A, Op den Camp HJ, Verweij PE. Bifidobacterium lipoteichoic acid and false ELISA reactivity in Aspergillus antigen detection. Lancet 363(9405), 325–327 (2004).
  • Meersseman W, Lagrou K, Maertens J et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am. J. Respir. Crit. Care Med. 177(1), 27–34 (2008).
  • Becker MJ, Lugtenburg EJ, Cornelissen JJ, Van Der Schee C, Hoogsteden HC, De Marie S. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br. J. Haematol. 121(3), 448–457 (2003).
  • Maertens J, Maertens V, Theunissen K et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin. Infect. Dis. 49(11), 1688–1693 (2009).
  • Husain S, Paterson DL, Studer SM et al. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 83(10), 1330–1336 (2007).
  • Pazos C, Pontón J, Del Palacio A. Contribution of (1->3)-β-d-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J. Clin. Microbiol. 43(1), 299–305 (2005).
  • Clancy CJ, Jaber RA, Leather HL et al. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J. Clin. Microbiol. 45(6), 1759–1765 (2007).
  • Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect. Dis. 9(2), 89–96 (2009).
  • Ruhnke M, Kujath P, Vogelaers D. Aspergillus in the intensive care unit. Curr. Fungal Infect. Rep. 6, 63–73 (2012).
  • White PL, Bretagne S, Klingspor L et al. Aspergillus PCR: one step closer to standardization. J. Clin. Microbiol. 48(4), 1231–1240 (2010).
  • Vanselow M, Brandt ME, Park BJ. Diagnosis and management of cryptococcal disease in resource-limited settings. Curr. Fungal Infect. Rep. 6(1), 35–45 (2012).
  • Garey KW, Rege M, Pai MP et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin. Infect. Dis. 43(1), 25–31 (2006).
  • Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob. Agents Chemother. 49(9), 3640–3645 (2005).
  • Caillot D, Casasnovas O, Bernard A et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J. Clin. Oncol. 15(1), 139–147 (1997).
  • Caillot D, Mannone L, Cuisenier B, Couaillier JF. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients. Clin. Microbiol. Infect. 7(Suppl. 2), 54–61 (2001).
  • Schuster MG, Edwards JE Jr, Sobel JD et al. Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann. Intern. Med. 149(2), 83–90 (2008).
  • Buchheidt D, Hummel M, Schleiermacher D et al. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br. J. Haematol. 125(2), 196–202 (2004).
  • Millon L, Piarroux R, Deconinck E et al. Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis. J. Clin. Microbiol. 43(10), 5097–5101 (2005).
  • Florent M, Katsahian S, Vekhoff A et al. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J. Infect. Dis. 193(5), 741–747 (2006).
  • Pazos C, Moragues MD, Quindós G, Pontón J, del Palacio A. Diagnostic potential of (1,3)-β-d-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients. Rev. Iberoam. Micol. 23(4), 209–215 (2006).
  • Nguyen MH, Wissel MC, Shields RK et al. Performance of Candida real-time polymerase chain reaction, β-d-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin. Infect. Dis. 54(9), 1240–1248 (2012).
  • León C, Ruiz-Santana S, Saavedra P et al. Value of β-d-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions. Intensive Care Med. 38(8), 1315–1325 (2012).
  • Pontón J, del Palacio A. [Advances and limitations in the early diagnosis of invasive yeast infections]. Rev. Iberoam. Micol. 24(3), 181–186 (2007).
  • Alam FF, Mustafa AS, Khan ZU. Comparative evaluation of (1, 3)-β-d-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect. Dis. 7, 103 (2007).
  • Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48(5), 503–535 (2009).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.